EYLEA

Описание к видео EYLEA

ted for the treatment of patients with neovascular (Wet) Age-related Macular Degeneration (AMD). Indicated for the treatment of patients with Macular Edema following Central Retinal Vein Occlusion (CRVO). EYLEA is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.

Комментарии

Информация по комментариям в разработке

Похожие видео